KATRINA HILLENBRAND: Open Payments
NPI 1770002099 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 16 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $120 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $152 |
| SpringWorks Therapeutics, Inc. | 2 | $152 |
| Janssen Biotech, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| SERVIER PHARMACEUTICALS LLC | 1 | $27 |
| Incyte Corporation | 1 | $25 |
| Genentech USA, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $23 |
| Tempus AI, Inc | 1 | $22 |
Products named: OGSIVEO, ENHERTU, CREON, FRUZAQLA, RYBREVANT, LYNPARZA, Tibsovo, JAKAFI.
Industry payments across IL — which companies pay providers there.
